Gyre Therapeutics, Inc. (GYRE)
NASDAQ: GYRE · Real-Time Price · USD
7.98
+0.08 (1.01%)
Dec 5, 2025, 4:00 PM EST - Market closed

Gyre Therapeutics Revenue

Gyre Therapeutics had revenue of $30.56M in the quarter ending September 30, 2025, with 19.92% growth. This brings the company's revenue in the last twelve months to $107.27M, up 2.13% year-over-year. In the year 2024, Gyre Therapeutics had annual revenue of $105.76M, down -6.78%.

Revenue (ttm)
$107.27M
Revenue Growth
+2.13%
P/S Ratio
6.50
Revenue / Employee
$185,259
Employees
579
Market Cap
725.31M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2024105.76M-7.69M-6.78%
Dec 31, 2023113.45M11.16M10.91%
Dec 31, 2022102.29M--